{ "ok": true, "cik": "1763329", "ticker": "AIBT", "name": "AIBOTICS, INC.", "filings": [ { "form": "8-K", "filed": "2026-10-05", "items": [ "1.01 Entry into a Material Definitive Agreement", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626001500/0001096906-26-001500-index.htm" }, { "form": "10-Q", "filed": "2026-08-19", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626001264/0001096906-26-001264-index.htm" }, { "form": "10-Q", "filed": "2026-06-09", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626000922/0001096906-26-000922-index.htm" }, { "form": "10-K", "filed": "2026-04-15", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/0001096906-26-000555-index.htm" }, { "form": "10-Q", "filed": "2025-11-19", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690625001895/0001096906-25-001895-index.htm" }, { "form": "10-Q", "filed": "2025-08-19", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690625001375/0001096906-25-001375-index.htm" } ], "events12m": 1, "healthWatch": { "window": "last 12 months", "since": "2025-10-06", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626000443/0001096906-26-000443-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 3, "latest": { "filed": "2026-08-14", "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626001231/0001096906-26-001231-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001763329.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1763329" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up AIBOTICS, INC. ($AIBT). Last filing: 8-K (1.01 Entry into a Material Definitive Agreement), 2026-10-05. 1 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 2183, "revenueGrowth1y": null, "revenueGrowthPerYear": null, "yearsOfData": 4, "operatingMargin": -845.0174072377462, "operatingMarginPrior": null, "netMargin": -1015.0027485112231, "operatingCashFlow": -458240, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 255940, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2018-12-31", "revenue": 0 }, { "fiscalYearEnd": "2019-12-31", "revenue": 0 }, { "fiscalYearEnd": "2024-12-31", "revenue": 0 }, { "fiscalYearEnd": "2025-12-31", "revenue": 2183 } ], "totalEquity": -3960232, "totalAssets": 874673, "equityRatio": -4.527671484086053, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": null, "sharesOutstanding": null, "bookValuePerShare": null, "revenuePerShare": null, "range80": null, "ifPaceHeld": null }, "edgarette": "🔖 Exposure: revenue $2K (FY2025). Experience: one year on record; operating margin -84501.7%, up from null. Soundness: equity -452.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin -84501.7% against a 0.7% median.", "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "summary": "Aibotics (AIBT) reported revenue of $0 million in FY2025, operating margin -84502% against a 0.7% median for medicinal chemicals & botanical products, equity -453% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
AIBOTICS, INC. against its own record and its peers
Operating marginPeer median 0.7%-84501.7%Equity of assetsPeer median 33.3%-452.8%Gold tick: the median of 8–8 peers with $50M+ revenue in medicinal chemicals & botanical products
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Aibotics (AIBT) reported revenue of $0 million in FY2025, operating margin -84502% against a 0.7% median for medicinal chemicals & botanical products, equity -453% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 2183, "totalDebt": null, "cash": 255940 }, "experience": { "revenueGrowth1y": null, "revenueGrowthPerYear": null, "operatingMargin": -845.0174072377462, "operatingMarginPrior": null, "netMargin": -1015.0027485112231, "freeCashFlow": null }, "soundness": { "equityRatio": -4.527671484086053, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "credibility": { "auditedYears": 4, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-10-06", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626000443/0001096906-26-000443-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 3, "latest": { "filed": "2026-08-14", "url": "https://www.sec.gov/Archives/edgar/data/1763329/000109690626001231/0001096906-26-001231-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": null, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001763329.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1763329" }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" }, { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$458K in FY2025)" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -458240, "investing": null, "financing": 529083, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2018-12-31", "operating": -68534, "free": null }, { "fiscalYearEnd": "2019-12-31", "operating": 98667, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": -259037, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -458240, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 255940, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 874673, "ladder": null, "currentRatio": 0.06, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" }, { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "cash", "text": "operating cash flow was negative (-$458K in FY2025)" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -458240, "investing": null, "financing": 529083, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2018-12-31", "operating": -68534, "free": null }, { "fiscalYearEnd": "2019-12-31", "operating": 98667, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": -259037, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -458240, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 255940, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 874673, "ladder": null, "currentRatio": 0.06, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }